Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 9 Nov 2019)

 

Open Access Review
Disease Resurgence, Production Capability Issues and Safety Concerns in the Context of an Aging Population: Is There a Need for a New Yellow Fever Vaccine?
by Kay M. Tomashek , Mark Challberg , Seema U. Nayak and Helen F. Schiltz
Vaccines 2019, 7(4), 179; https://doi.org/10.3390/vaccines7040179 (registering DOI) – 08 Nov 2019
Abstract
Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine. This trend has increased the level of concern about the disease and the potential for importation to areas in Asia with ecological conditions that can sustain yellow fever virus transmission. In this article, we provide a broad overview of yellow fever burden of disease, natural history, treatment, vaccine, prevention and control initiatives, and vaccine and therapeutic agent development efforts